Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Accenture
Dow
Medtronic
Chubb
Argus Health
QuintilesIMS
McKesson
Chinese Patent Office

Generated: August 21, 2018

DrugPatentWatch Database Preview

AUVI-Q Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Auvi-q, and what generic alternatives are available?

Auvi-q is a drug marketed by Kaleo Inc and is included in one NDA. There are twenty-four patents protecting this drug.

This drug has one hundred and three patent family members in fourteen countries.

The generic ingredient in AUVI-Q is epinephrine. There are nineteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the epinephrine profile page.

Summary for AUVI-Q
International Patents:103
US Patents:24
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 71
Patent Applications: 4,402
Formulation / Manufacturing:see details
DailyMed Link:AUVI-Q at DailyMed
Drug patent expirations by year for AUVI-Q
Synonyms for AUVI-Q
(-)-(R)-Epinephrine
(-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(-)-Adrenalin
(-)-Adrenaline
(-)-Epinephrine
(-)-Epinephrine, >=97.0% (NT)
(-)-Epinephrine;L-Adrenaline;(-)-Adrenalin
(-)-R-Epinephrine
(+/-)-3,4-Dihydroxy-alpha-(methylaminomethyl)benzyl alcohol
(+/-)-Adrenalin
(R)-(-)-3,4-Dihydroxy-alpha-(methylaminomethyl)benzyl alcohol
(R)-(-)-Adnephrine
(R)-(-)-Adrenaline
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(r)-4-(1-hydroxy-2-(methylamino)ethyl)benzene-1,2-diol
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-Adrenaline
(R)-Epinephrine
1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
1-Adrenalin
1-Epinephrine
1,2-Benzenediol, 4-((1R)-1-hydroxy-2-(methylamino)ethyl)-
1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (R)-
1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (theta)-
1,2-Benzenediol, 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]-
1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-, (R)-
1401-EP2270011A1
1401-EP2298735A1
1401-EP2301934A1
1401-EP2305677A1
1401-EP2308562A2
1401-EP2308861A1
1401-EP2311464A1
1401-EP2311823A1
1401-EP2314571A2
2,3-bis(oxidanyl)butanedioic acid;4-[(1R)-2-(methylamino)-1-oxidanyl-ethyl]benzene-1,2-diol
2,3-dihydroxybutanedioic acid;4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
204017-EP2277867A2
204017-EP2280003A2
3,4-Dihydroxy-.alpha.-((methylamino)methyl)benzyl alcohol
3,4-Dihydroxy-alpha-(methylaminomethyl)benzyl alcohol
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]pyrocatechol;tartaric acid
4-[(1R)-1-hydroxy-2-methylamino-ethyl]benzene-1,2-diol
4-[(1R)-1-hydroxy-2-methylaminoethyl]benzene-1,2-diol
4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol #
4,5-beta-trihydroxy-N-methylphenethylamine
51-43-4
51-43-4 (FREE BASE)
51028-73-0
6367-EP2272841A1
6367-EP2277861A1
6367-EP2301934A1
6367-EP2301936A1
6367-EP2314571A2
91382-EP2284149A1
91382-EP2305636A1
A0173
AB00573227_14
AB00573227_15
AB00573227-11
AB00573227-12
AB00573227-13
AB2000623
AC-13188
AC1L1L7B
Adnephrine
ADR ADRENALINE
Adrenaclick
Adrenal
Adrenalin
Adrenalin (TN)
Adrenalin chloride
Adrenalin in Oil
Adrenalin-Medihaler
Adrenalina
Adrenalina [DCIT]
adrenaline
Adrenaline (JP15)
Adrenaline (JP17)
Adrenaline (L-Adrenaline)
Adrenaline with impurity F, European Pharmacopoeia (EP) Reference Standard
Adrenaline, European Pharmacopoeia (EP) Reference Standard
Adrenaline/Epinephrine
Adrenalinum
Adrenamine
Adrenan
Adrenapax
Adrenasol
Adrenatrate
Adrenine
Adrenodis
Adrenohorma
Adrenosan
Adrenutol
Adrin
Adrine
ADROP
AI3-19015
AJ-08814
AKOS024283500
ALE
AN-15872
Ana-Guard
Ana-Kit
Antiasthmatique
AS-13813
Asmatane Mist
Asthma meter mist
Asthma-nefrin
Asthmahaler Mist
Asthmanefrin
Astmahalin
Astminhal
Auvi-q (TN)
Auvi-Q auto-injector
Balmadren
BC204174
BDBM44818
BDBM50029050
Benzyl alcohol, 3,4-dihydroxy-.alpha.-[(methylamino)methyl]-, (-)-
Benzyl alcohol, 3,4-dihydroxy-alpha-((methylamino)methyl)-, (-)-
Bernarenin
BIDD:GT0119
Biorenine
bmse000316
Bosmin
Brevirenin
Bronkaid
Bronkaid Mist
Bronkaid Suspension Mist
Bupivacaine Hcl and Epinephrine
C00788
C9H13NO3
CAS-51-43-4
CCG-204593
CCRIS 4812
CHEBI:28918
Chelafrin
CHEMBL679
cid_6852374
Citanest Forte
Citanest Forte (Salt/Mix)
component of E-Pilo (Salt/Mix)
Corisol
CS-2558
CTK4J3509
d-Adrenaline
D-Epifrin
D-Epinephrine
D00095
D29A657
DB00668
Drenamist
DSSTox_CID_2986
DSSTox_GSID_22986
DSSTox_RID_76819
DTXSID5022986
Dylephrin
Dyspne-Inhal
E4250_SIGMA
EINECS 200-098-7
EPI E Z PEN JR
Epi EZ Pen Jr
Epifrin
Epiglaufrin
Epinefrin
Epinefrin [Czech]
Epinefrina
Epinefrina [INN-Spanish]
Epinephran
epinephrine
EPINEPHRINE (SEE ALSO: EPINEPHRINE HYDROCHLORIDE (CAS 55-31-2))
Epinephrine (USP)
Epinephrine (USP/INN)
Epinephrine [USAN:INN:JAN]
Epinephrine [USP:INN:BAN:JAN]
Epinephrine HCl
Epinephrine hydrochloride
Epinephrinum
Epinephrinum [INN-Latin]
Epipen
Epipen (TN)
Epipen Auto-Injector
EPIPEN E Z PEN
Epipen EZ Pen
EPIPEN JR
Epipen Jr.
Epipen Jr. Auto-Injector
Epirenamine
Epirenan
Epirenin
Epitrate
Epitrate (Salt/Mix)
Eppy
Esphygmogenina
Exadri
Exadrin
Glaucon
Glaucosan
Glauposine
Glycirenan
GTPL479
Haemostasin
Haemostatin
Hektalin
Hemisine
Hemostasin
Hemostatin
HSCI1_000215
HSDB 4289
HY-B0447B
Hypernephrin
Hyporenin
Intranefrin
Iontocaine
IOP
Isoptoepinal
J10365
Kidoline
l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
l-Adrenalin
l-Adrenaline
L-Adrenaline (Epinephrine)
L-Adrenaline Base
l-adrenaline,(-)adrenaline,l-epinephrine,l-3,4-dihydroxy-alpha-(methylaminomethyl)benzyl alcohol,l-1-methyl aminoethanol catechol
L-Epinehphrine
l-Epinephine
L-epinephrine
l-Epinephrine (synthetic)
l-Epirenamine
l-Methylaminoethanolcatechol
L(-)-Epinephrine
L926
Levo-Methylaminoethanolcatechol
Levoadrenaline
Levoepinephrine
Levorenen
Levorenin
Levorenine
Levoreninum
Lopac-E-4642
LS-156
Lyodrin
Lyophrin
MCULE-9462717294
Medihaler-Epi
Metanephrin
Methylaminoethanolcatechol
Methylarterenol
MFCD00002204
MFCD00063027
Micronefrin
MolPort-002-051-368
Mucidrina
Myosthenine
Mytrate
NCGC00015417-01
NCGC00142615-01
NCGC00142615-03
NCGC00142615-04
NCGC00142615-05
NCGC00142615-06
NCGC00142615-07
NCGC00142615-08
NCGC00142615-09
nchembio747-comp9
NE58416
Nephridine
Nieraline
NSC 62786
NSC62786
OR023601
OR154878
OR276267
OR349940
Paranephrin
PDSP1_001120
PDSP2_001104
Primatene
Primatene Mist
Q-200601
R-(-)-Epinephrine
R-Adrenaline
RCRA waste no. P042
Rcra waste number P042
Renagladin
Renaglandin
Renaglandulin
Renaleptine
Renalina
Renoform
Renostypricin
Renostypticin
Renostyptin
s2522
SBB012384
SCHEMBL3814
Scurenaline
Septocaine
Simplene
Sindrenina
SMP1_000227
Soladren
Sphygmogenin
SR-01000075267-8
ST069368
Stryptirenal
Styptirenal
Supracapsulin
Supradin
Supranefran
Supranephrane
Supranephrine
Supranol
Suprarenaline
Suprarenin
Suprel
Surenine
Surrenine
Sus-Phrine
SUS-PHRINE SULFITE-FREE
Susphrine
Symjepi
Sympathin I
Takamina
Takamine
Tokamina
Tonogen
Tox21_111562
Tox21_111562_1
TR-033467
Twinject
Twinject 0.15
Twinject 0.3
Twinject 0.30
UCTWMZQNUQWSLP-VIFPVBQESA-N
UNII-GR0L9S3J0F component UCTWMZQNUQWSLP-VIFPVBQESA-N
UNII-YKH834O4BH
Vaponefrin
Vasoconstrictine
Vasoconstrictor
Vasodrine
Vasoton
Vasotonin
YKH834O4BH
Z2686405805
ZINC39089

US Patents and Regulatory Information for AUVI-Q

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kaleo Inc AUVI-Q epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 201739-002 Aug 10, 2012 BX RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Kaleo Inc AUVI-Q epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 201739-002 Aug 10, 2012 BX RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Kaleo Inc AUVI-Q epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 201739-001 Aug 10, 2012 BX RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Non-Orange Book US Patents for AUVI-Q

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,899,987 Simulated medicament delivery device having an electronic circuit system ➤ Try a Free Trial
9,278,177 Medical injector with compliance tracking and monitoring ➤ Try a Free Trial
8,544,645 Devices, systems and methods for medicament delivery ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Deloitte
Covington
Federal Trade Commission
QuintilesIMS
Accenture
AstraZeneca
Teva
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.